Ruben Gonzalez None;
Justin Huynh None;
Evan Walker None;
Bharanidharan Saseendrakumar None;
Christopher Bowd None;
Akram Belghith None;
Michael Goldbaum None;
Massimo Fazio National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Topcon and Wolfram Research, Code F (Financial Support);
Christopher Girkin National Eye Institute, Heidelberg Engineering, Topcon, EyeSight Foundation of Alabama, Research to Prevent Blindness, GmbH, Code F (Financial Support);
Gustavo De Moraes Novartis, Galimedix, Belite, Reichert, Carl Zeiss, Perfuse Therapeutics, Code C (Consultant/Contractor), Ora Clinical, Code E (Employment), Heidelberg, Topcon, Code R (Recipient);
Jeffrey Liebmann Allergan, Genentech, Thea, Bausch & Lomb, Code C (Consultant/Contractor), Novartis, Research to Prevent Blindness, Code F (Financial Support);
Robert Weinreb Abbvie, Aerie Pharmaceuticals, Allergan, Equinox, Iantrek, Implandata, Nicox, Topcon Medical , Code C (Consultant/Contractor), Bausch & Lomb, Topcon Medical, Heidelberg Engineering, Carl Zeiss Meditec, Optovue, Centervue , Code F (Financial Support), Toromedes, Carl Zeiss Meditec, Code P (Patent);
Sally Baxter voxelcloud.io, Code C (Consultant/Contractor), Optomed, Topcon, Code F (Financial Support), iVista Medical Education, Code I (Personal Financial Interest);
Linda Zangwill Abbvie Inc., Topcon, Code C (Consultant/Contractor), National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc., Topcon Medical Systems Inc., Code F (Financial Support), Zeiss Meditec, AISight Health, Code P (Patent);
Mark Christopher AISight Health, Code P (Patent)